お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
536336

世界のウェアラブルインジェクター市場:規模、シェア、発展、成長率、需要予測

Global Wearable Injectors Market Size, Share, Development, Growth and Demand Forecast to 2024

出版日: | 発行: Prescient & Strategic Intelligence Private Limited | ページ情報: 英文 179 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=109.37円
世界のウェアラブルインジェクター市場:規模、シェア、発展、成長率、需要予測
出版日: 2017年03月01日
発行: Prescient & Strategic Intelligence Private Limited
ページ情報: 英文 179 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界のウェアラブルインジェクター (注射器) 市場について調査分析し、市場規模と予測、地域別分析、競合情勢、企業プロファイルについて、体系的な情報を提供しています。

第1章 調査範囲・手法

第2章 エグゼクティブサマリー

第3章 市場の見通し

  • イントロダクション
  • 市場の機会
  • 新興国での導入
  • 市場促進要因
  • 市場阻害要因

第4章 世界のウェアラブルインジェクター市場規模と予測

  • 種類別
  • 技術別
  • 用途別
  • エンドユーザー別
  • 地域別

第5章 世界のウェアラブルインジェクター市場:種類別

  • 装着式パッチインジェクター
  • 非装着式ベルトインジェクター
  • ボーラスインジェクター

第6章 世界のウェアラブルインジェクター市場:技術別

  • 電子的
  • 機械的

第7章 世界のウェアラブルインジェクター市場:用途別

  • がん
  • 感染症
  • 自己免疫疾患
  • 心血管疾患
  • 血液疾患

第8章 世界のウェアラブルインジェクター市場:エンドユーザー別

  • 在宅
  • 病院
  • ラボ・診断

第9章 世界のウェアラブルインジェクター市場:地域別

  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ
  • ファイブフォース分析
  • 競合ポジショニング
  • 競合ベンチマーキング
  • 市場シェア分析

第10章 企業プロファイルと戦略的発展

  • 主要企業プロファイル
    • Becton, Dickinson and Company
    • Medtronic plc
    • Johnson & Johnson
    • F. Hoffmann-La Roche Ltd.
    • Unilife Corporation
    • CeQur SA
    • Sensile Medical AG
    • Enable Injections
    • ScPharmaceuticals, Inc.
    • SteadyMed Ltd.
    • Insulet Corporation
    • Ypsomed Group
    • West Pharmaceutical Services, Inc.
    • Buhler Motor GmbH
    • Cane S.p.A
  • 戦略的発展

第11章 付録

目次

Market Overview:

A wearable injector is a device used for delivering large volume of drugs over an extended time period. It delivers large subcutaneous drug doses to patients, even when the patient is ambulatory and can carry out normal daily activities during drug delivery.

Based on type, the global wearable injectors market has been segmented into body-worn patch injector, off-body worn belt injector and bolus injector. The bolus injector segment, though introduced in 2016, is expected to witness the highest growth during the forecast period, owing to its ability to treat various diseases such as cancer, auto-immune disease, infectiuos disease, cardiovasulcar disease and blood disorder.

WEARABLE INJECTORS MARKET:

Based on application, the global wearable injectors market is segmented into cancer, infectious disease, autoimmune disorder, cardiovascular disease, blood disorder and others. Cancer is expected to be the largest application area of the global wearable injectors market during 2016 - 2024. Homecare, hospital, lab and diagnostics are the key end users of wearable injectors. Homecare was the largest end user segment of the global wearable injectors market in 2015. Homecare setup is convenient and improves quality of life of the patient, as it reduces patient's visits to the hospital. High prevalence of chronic diseases, increasing demand for self-injection system and growing geriatric population are the key drivers for the growth of the global wearable injectors market for homecare.

North America was the largest region for body-worn patch injector in 2016, and is expected to grow at a CAGR of 7.3%, during the forecast period. The North American wearable injectors market is growing due to increasing demand for self-injection system and rising prevalence of chronic and lifestyle-associated diseases. According to the CDC, approximately 117 million people in the U.S., i.e. about half of its adult population, experienced one or more chronic health conditions in 2012.

Market Dynamics:

The global wearable injectors market is expected to grow at a CAGR of 23.0% during 2016-2024.The elderly population requires extensive care, as they are prone to illness due to low immunity levels and longer recovery time. The global market is driven by various factors such as growing burden of geriatric population, increasing prevalence of chronic diseases and high demand for advanced drug delivery. The emerging economies offer ample growth opportunities for the growth of wearable injectors market. However, alternative drug delivery methods hinder the growth of the global wearable injectors market.

Trends:

The key trend observed in the global wearable injectors market is the increasing use of wearable injectors for treating chronic diseases. The wearable injectors market is developing globally, owing to the increasing demand for advanced medical devices and increased focus on homecare health. Wearable injectors create reliable and consistent user experience, as these are attached to patient's body delivering the drugs, when the user is still performing their daily activities. Thus, pharmaceutical companies having huge pipeline for chronic diseases are looking forward to collaborating with the device manufacturers for drug device combination and obtaining better patient outcomes. Also, the preinstalled drug is helpful in getting better patient ease by self-administration, helping the end user to reduce the overall cost incurred on healthcare.

Growth Drivers:

Some of the factors driving the growth of the wearable injectors market include growing need for home healthcare and an urge to reduce overall healthcare costs. Hospitals are focusing on reducing patient's stay in hospital and healthcare cost incurred. To save on healthcare costs and maintain patient comfort, device manufacturers are focusing to develop advanced drug delivery devices. Wearable injector is one of the most suitable solutions for patients suffering from various chronic diseases, who are in the need to visit doctors frequently for better health management.

The increased life expectancy and fall in birth rates are the major cause of aging population. The elderly patients require extensive care, as they are prone to illness due to low immunity level and longer recovery time and are therefore more susceptible to chronic diseases, such as cancer, diabetes, neurological disorders and cardiovascular diseases. With the increase in aging population, the demand for drugs is expected to increase, leading to the growth in demand of wearable injectors for frequent drug administration.

Competitive Landscape:

The global wearable injectors market reported a consolidated structure in 2015, where the top three competitors accounted for the major share. Some of the key players in the global market includes Becton, Dickinson and Company, Medtronic plc, Johnson & Johnson, F. Hoffmann-La Roche Ltd., Insulet Corporation, Unilife Corporation, Enable Injections, SteadyMed Ltd., Ypsomed Group, West Pharmaceutical Services, Inc.

Scope for Customization:

P&S Market Research offers customization as per specific business requirements of clients. Illustrative customization within the scope of this report includes:

  • Period of Analysis - Increase in the study period, including historic and forecast years
  • Geographical Analysis - Increase in country coverage
  • Company Profiles - Wider company coverage in terms of detailed analysis or additional company profiles
  • New custom report - A completely customized report can be provided on the market, specific to a region/ country/ segment

Table of Content

Chapter 1. Research Scope and Methodology

  • 1.1 Market Definition
  • 1.2 Research Scope
    • 1.2.1 Market segmentation by type
    • 1.2.2 Market segmentation by technology
    • 1.2.3 Market segmentation by application
    • 1.2.4 Market segmentation by end user
    • 1.2.5 Market segmentation by geography
  • 1.3 Research Methodology and Sources

Chapter 2. Executive Summary

  • 2.1 Key Findings
  • 2.2 Research Summary

Chapter 3. Market Outlook

  • 3.1 Introduction
  • 3.2 Opportunities in the Global Wearable Injectors Market
  • 3.3 Adoption of wearable injectors in emerging economies
  • 3.4 Factors Driving the Growth of the Market and its Impact on Market Forecast
    • 3.4.1 Growing burden of geriatric population
    • 3.4.2 Increasing prevalence of chronic diseases
    • 3.4.3 Rising demand for advanced drug delivery
    • 3.4.4 Impact analysis of drivers on market forecast
  • 3.5 Factors Hindering Growth of the Market and its Impact on Market Forecast
    • 3.5.1 Alternative drug delivery methods
    • 3.5.2 Issues associated with the use of wearable injectors
    • 3.5.3 Impact analysis of restraints on market forecast

Chapter 4. Global Wearable Injectors Market Size and Forecast (2012 - 2024)

  • 4.1 Global Wearable Injectors Market, by Type
  • 4.2 Global Wearable Injectors Market, by Technology
  • 4.3 Global Wearable Injectors Market, by Application
  • 4.4 Global Wearable Injectors Market, by End User
  • 4.5 Global Wearable Injectors Market, by Region

Chapter 5. Global Wearable Injectors Market, by Type

  • 5.1 Body-Worn Patch Injectors Market
    • 5.1.1 Global body-worn patch injectors market, by region
  • 5.2 Off-Body Worn Belt Injectors Market
    • 5.2.1 Global off-body worn belt injectors market, by region
  • 5.3 Bolus Injectors Market
    • 5.3.1 Global bolus injectors market, by region

Chapter 6. Global Wearable Injectors Market, by Technology

  • 6.1 Electronic Wearable Injectors Market
    • 6.1.1 Global electronic wearable injectors market, by region
  • 6.2 Mechanical Wearable Injectors Market
    • 6.2.1 Global mechanical wearable injectors market, by region

Chapter 7. Global Wearable Injectors Market, by Application

  • 7.1 Wearable Injectors Market for Cancer
    • 7.1.1 Global wearable injectors market for cancer, by region
  • 7.2 Wearable Injectors Market for Infectious Disease
    • 7.2.1 Global wearable injectors market for infectious disease, by region
  • 7.3 Wearable Injectors Market for Autoimmune Disorder
    • 7.3.1 Global wearable injectors for autoimmune disorder, by region
  • 7.4 Wearable Injectors Market for Cardiovascular Disease
    • 7.4.1 Global wearable injectors market for cardiovascular disease, by region
  • 7.5 Wearable Injectors Market for Blood Disorder
    • 7.5.1 Global wearable injectors market for blood disorder, by region

Chapter 8. Global Wearable Injectors Market, by End User

  • 8.1 Wearable Injectors Market for Homecare
    • 8.1.1 Global wearable injectors market for homecare, by region
  • 8.2 Wearable Injectors Market for Hospital
    • 8.2.1 Global wearable injectors market for hospital, by region
  • 8.3 Wearable Injectors Market for Lab & Diagnostics
    • 8.3.1 Global wearable injectors market for lab & diagnostics, by region

Chapter 9. Global Wearable Injectors Market, by Geography

  • 9.1 North America Wearable Injectors Market
    • 9.1.1 North America wearable injectors market, by type
    • 9.1.2 North America wearable injectors market, by technology
    • 9.1.3 North America wearable injectors market, by application
    • 9.1.4 North America wearable injectors market, by end user
    • 9.1.5 North America wearable injectors market, by country
  • 9.2 Europe Wearable Injectors Market
    • 9.2.1 Europe wearable injectors market, by type
    • 9.2.2 Europe wearable injectors market, by technology
    • 9.2.3 Europe wearable injectors market, by application
    • 9.2.4 Europe wearable injectors market, by end user
    • 9.2.5 Europe wearable injectors market, by country
  • 9.3 APAC Wearable Injectors Market
    • 9.3.1 APAC wearable injectors market, by type
    • 9.3.2 APAC wearable injectors market, by technology
    • 9.3.3 APAC wearable injectors market, by application
    • 9.3.4 APAC wearable injectors market, by end user
    • 9.3.5 APAC wearable injectors market, by country
  • 9.4 Latin America Wearable Injectors Market
    • 9.4.1 Latin America wearable injectors market, by type
    • 9.4.2 Latin America wearable injectors market, by technology
    • 9.4.3 Latin America wearable injectors market, by application
    • 9.4.4 Latin America wearable injectors market, by end user
    • 9.4.5 Latin America wearable injectors market, by country
  • 9.5 MEA Wearable Injectors Market
    • 9.5.1 MEA wearable injectors market, by type
    • 9.5.2 MEA wearable injectors market, by technology
    • 9.5.3 MEA wearable injectors market, by application
    • 9.5.4 MEA wearable injectors market, by end user
  • 9.6 Porter's Five Forces of Competitive Position Analysis
    • 9.6.1 Bargaining power of buyers
    • 9.6.2 Bargaining power of suppliers
    • 9.6.3 Threat of new entrants
    • 9.6.4 Intensity of rivalry
    • 9.6.5 Threat of substitutes
  • 9.7 Competitive Positioning of the Global Wearable Injectors Market, by Type
  • 9.8 Competitive Benchmarking of Key Players Based on Types of Offering
  • 9.9 Market Share Analysis of the Global Wearable Injectors Market

Chapter 10. Company Profiles and Strategic Developments

  • 10.1 Key Company Profiles
    • 10.1.1 Becton, Dickinson and Company
      • 10.1.1.1 Business overview
      • 10.1.1.2 Product and service offerings
    • 10.1.2 Medtronic plc
      • 10.1.2.1 Business overview
      • 10.1.2.2 Product and service offerings
    • 10.1.3 Johnson & Johnson
      • 10.1.3.1 Business overview
      • 10.1.3.2 Product and service offerings
    • 10.1.4 F. Hoffmann-La Roche Ltd.
      • 10.1.4.1 Business overview
      • 10.1.4.2 Product and service offerings
    • 10.1.5 Unilife Corporation
      • 10.1.5.1 Business overview
      • 10.1.5.2 Product and service offerings
    • 10.1.6 CeQur SA
      • 10.1.6.1 Business overview
      • 10.1.6.2 Product and service offerings
    • 10.1.7 Sensile Medical AG
      • 10.1.7.1 Business overview
      • 10.1.7.2 Product and service offerings
    • 10.1.8 Enable Injections
      • 10.1.8.1 Business overview
      • 10.1.8.2 Product and service offerings
    • 10.1.9 ScPharmaceuticals, Inc.
      • 10.1.9.1 Business overview
      • 10.1.9.2 Product and service offerings
    • 10.1.10 SteadyMed Ltd.
      • 10.1.10.1 Business overview
      • 10.1.10.2 Product and service offerings
    • 10.1.11 Insulet Corporation
      • 10.1.11.1 Business overview
      • 10.1.11.2 Product and service offerings
    • 10.1.12 Ypsomed Group
      • 10.1.12.1 Business overview
      • 10.1.12.2 Product and service offerings
    • 10.1.13 West Pharmaceutical Services, Inc.
      • 10.1.13.1 Business overview
      • 10.1.13.2 Product and service offerings
    • 10.1.14 Buhler Motor GmbH
      • 10.1.14.1 Business overview
      • 10.1.14.2 Product and service offerings
    • 10.1.15 Cane S.p.A.
      • 10.1.15.1 Business overview
      • 10.1.15.2 Product and service offerings
  • 10.2 Strategic Developments in the Global Wearable Injectors Market

Chapter 11. Appendix

  • 11.1 List of Abbreviations

LIST OF TABLES

  • TABLE 1: Specific primary and secondary sources used for this publication
  • TABLE 2: Global Wearable Injectors Market Snapshot
  • TABLE 3: Number of deaths worldwide Due to Various Diseases
  • TABLE 4: Commercially available drugs for large subcutaneous delivery
  • TABLE 5: Drivers for The Market: Impact Analysis
  • TABLE 6: Restraints for The Market: Impact Analysis
  • TABLE 7: Global Wearable injectors market, by type, $m (2012 - 2015)
  • TABLE 8: Global Wearable injectors market, by type, $m (2016 - 2024)
  • TABLE 9: Global Wearable injectors market, by technology, $m (2012 - 2015)
  • TABLE 10: Global Wearable injectors market, by technology, $m (2016 - 2024)
  • TABLE 11: Global Wearable injectors market, by Application, $m (2012 - 2015)
  • TABLE 12: Global Wearable injectors market, by Application, $m (2016 - 2024)
  • TABLE 13: Global Wearable injectors market, by end user, $m (2012 - 2015)
  • TABLE 14: Global Wearable injectors market, by end user, $m (2016 - 2024)
  • TABLE 15: Global Wearable injectors market, by region, $m (2012 - 2015)
  • TABLE 16: Global Wearable injectors market, by region, $m (2016 - 2024)
  • TABLE 17: Global body-worn patch injectors market, by region, $m (2012 - 2015)
  • TABLE 18: Global body-worn patch injectors market, by region, $m (2016 - 2024)
  • TABLE 19: Global off-body worn belt injectors market, by region, $m (2012 - 2015)
  • TABLE 20: Global off-body worn belt injectors market, by region, $m (2016 - 2024)
  • TABLE 21: Global BOLUS INJECTORs market, by region, $m (2016 - 2024)
  • TABLE 22: Global Electronic wearable injectors market, by Region, $m (2012 - 2015)
  • TABLE 23: Global Electronic wearable injectors market, by region, $m (2016 - 2024)
  • TABLE 24: Global Mechanical wearable injectors market, by Region, $m (2012 - 2015)
  • TABLE 25: Global Mechanical wearable injectors market, by region, $m (2016 - 2024)
  • TABLE 26: Global wearable injectors market for cancer, by Region, $m (2012 - 2015)
  • TABLE 27: Global wearable injectors market for cancer, by region, $m (2016 - 2024)
  • TABLE 28: Global wearable injectors market for infectious disease, by Region, $m (2012 - 2015)
  • TABLE 29: Global wearable injectors market for infectious disease, by region, $m (2016 - 2024)
  • TABLE 30: Global wearable injectors market for autoimmune disorder, by Region, $m (2012 - 2015)
  • TABLE 31: Global wearable injectors market for autoimmune disorder, by region, $m (2016 - 2024)
  • TABLE 32: Global wearable injectors Market for Cardiovascular Disease, by Region, $m (2012 - 2015)
  • TABLE 33: Global wearable injectors market for Cardiovascular Disease, by region, $m (2016 - 2024)
  • TABLE 34: Global wearable injectors market for blood disorder, by Region, $m (2012 - 2015)
  • TABLE 35: Global wearable injectors market for blood disorder, by region, $m (2016 - 2024)
  • TABLE 36: Global wearable injectors market for homecare, by Region, $m (2012 - 2015)
  • TABLE 37: Global wearable injectors market for homecare, by region, $m (2016 - 2024)
  • TABLE 38: Global wearable injectors market for hospital, by Region, $m (2012 - 2015)
  • TABLE 39: Global wearable injectors market for hospital, by region, $m (2016 - 2024)
  • TABLE 40: Global wearable injectors market for Lab & Diagnostics, by Region, $m (2012 - 2015)
  • TABLE 41: Global wearable injectors market for Lab & Diagnostics, by region, $m (2016 - 2024)
  • TABLE 42: North America Wearable injectors market, by type, $m (2012 - 2015)
  • TABLE 43: North America Wearable injectors market, by type, $m (2016 - 2024)
  • TABLE 44: North America Wearable injectors market, by technology, $m (2012 - 2015)
  • TABLE 45: North America Wearable injectors market, by technology, $m (2016 - 2024)
  • TABLE 46: North America Wearable injectors market, by application, $m (2012 - 2015)
  • TABLE 47: North America Wearable injectors market, by application, $m (2016 - 2024)
  • TABLE 48: North America Wearable injectors market, by end user, $m (2012 - 2015)
  • TABLE 49: North America Wearable injectors market, by end user, $m (2016 - 2024)
  • TABLE 50: North America Wearable injectors market, by COUNTRY, $m (2012 - 2015)
  • TABLE 51: North America Wearable injectors market, by country, $m (2016 - 2024)
  • TABLE 52: Europe Wearable injectors market, by type, $m (2012 - 2015)
  • TABLE 53: Europe Wearable injectors market, by type, $m (2016 - 2024)
  • TABLE 54: Europe Wearable injectors market, by technology, $m (2012 - 2015)
  • TABLE 55: Europe Wearable injectors market, by technology, $m (2016 - 2024)
  • TABLE 56: Europe Wearable injectors market, by application, $m (2012 - 2015)
  • TABLE 57: Europe Wearable injectors market, by application, $m (2016 - 2024)
  • TABLE 58: Europe Wearable injectors market, by end user, $m (2012 - 2015)
  • TABLE 59: Europe Wearable injectors market, by end user, $m (2016 - 2024)
  • TABLE 60: Europe Wearable injectors market, by COUNTRY, $m (2012 - 2015)
  • TABLE 61: Europe Wearable injectors market, by country, $m (2016 - 2024)
  • TABLE 62: APAC Wearable injectors market, by type, $m (2012 - 2015)
  • TABLE 63: APAC Wearable injectors market, by type, $m (2016 - 2024)
  • TABLE 64: APAC Wearable injectors market, by technology, $m (2012 - 2015)
  • TABLE 65: APAC Wearable injectors market, by technology, $m (2016 - 2024)
  • TABLE 66: APAC Wearable injectors market, by application, $m (2012 - 2015)
  • TABLE 67: APAC Wearable injectors market, by application, $m (2016 - 2024)
  • TABLE 68: APAC Wearable injectors market, by end user, $m (2012 - 2015)
  • TABLE 69: APAC Wearable injectors market, by end user, $m (2016 - 2024)
  • TABLE 70: APAC Wearable injectors market, by COUNTRY, $m (2012 - 2015)
  • TABLE 71: APAC Wearable injectors market, by country, $m (2016 - 2024)
  • TABLE 72: Latin America Wearable injectors market, by type, $m (2012 - 2015)
  • TABLE 73: Latin America Wearable injectors market, by type, $m (2016 - 2024)
  • TABLE 74: Latin America Wearable injectors market, by technology, $m (2012 - 2015)
  • TABLE 75: Latin America Wearable injectors market, by technology, $m (2016 - 2024)
  • TABLE 76: Latin America Wearable injectors market, by application, $m (2012 - 2015)
  • TABLE 77: Latin America Wearable injectors market, by application, $m (2016 - 2024)
  • TABLE 78: Latin America Wearable injectors market, by end user, $m (2012 - 2015)
  • TABLE 79: Latin America Wearable injectors market, by end user, $m (2016 - 2024)
  • TABLE 80: Latin America Wearable injectors market, by COUNTRY, $m (2012 - 2015)
  • TABLE 81: Latin America Wearable injectors market, by country, $m (2016 - 2024)
  • TABLE 82: MEA Wearable injectors market, by type, $m (2012 - 2015)
  • TABLE 83: MEA Wearable injectors market, by type, $m (2016 - 2024)
  • TABLE 84: MEA Wearable injectors market, by technology, $m (2012 - 2015)
  • TABLE 85: MEA Wearable injectors market, by technology, $m (2016 - 2024)
  • TABLE 86: MEA Wearable injectors market, by application, $m (2012 - 2015)
  • TABLE 87: MEA Wearable injectors market, by application, $m (2016 - 2024)
  • TABLE 88: MEA Wearable injectors market, by end user, $m (2012 - 2015)
  • TABLE 89: MEA Wearable injectors market, by end user, $m (2016 - 2024)
  • TABLE 90: BECTON, DICKINSON AND COMPANY - Key Facts
  • TABLE 91: Medtronic plc- Key Facts
  • TABLE 92: Johnson & Johnson - Key Facts
  • TABLE 93: F. Hoffmann-La roche ltd. - Key Facts
  • TABLE 94: Unilife Corporation - Key Facts
  • TABLE 95: Cequr SA - Key Facts
  • TABLE 96: SEnsile Medical AG - Key Facts
  • TABLE 97: Enable Injections - Key Facts
  • TABLE 98: Scpharmaceuticals INC. - Key Facts
  • TABLE 99: SteadyMed Ltd. - Key Facts
  • TABLE 100: Insulet Corporation - Key Facts
  • TABLE 101: Ypsomed Group - Key Facts
  • TABLE 102: West Pharmaceutical Services, Inc. - Key Facts
  • TABLE 103: Buhler Motor GmbH - Key Facts
  • TABLE 104: Cane S.p.A. - Key Facts

LIST OF FIGURES

  • FIG 1: RESEARCH SCOPE FOR GLOBAL WEARABLE INJECTORS MARKET
  • FIG 2: RESEARCH METHODOLOGY FOR GLOBAL WEARABLE INJECTORS MARKET
  • FIG 3: AGING POPULATION AS A PERCENTAGE OF TOTAL POPULATION
  • FIG 4: GLOBAL INCIDENCE OF CANCER (EXCLCLUDING NON-MELANOMA SKIN CANCER) (2015)
  • FIG 5: GLOBAL DIABETIC POPULATION, AGED 20-79 YEARS (2013)
  • FIG 6: GLOBAL WEARABLE INJECTORS MARKET, $M (2012 - 2024)
  • FIG 7: GLOBAL WEARABLE INJECTORS MARKET, BY TYPE, $M (2012 - 2024)
  • FIG 8: GLOBAL WEARABLE INJECTORS MARKET SPLIT, BY TYPE (2016)
  • FIG 9: GLOBAL WEARABLE INJECTORS MARKET, BY TECHNOLOGY, $M (2012 - 2024)
  • FIG 10: GLOBAL WEARABLE INJECTORS MARKET SPLIT, BY TECHNOLOGY (2016)
  • FIG 11: GLOBAL WEARABLE INJECTORS MARKET, BY APPLICATION, $M (2012 - 2024)
  • FIG 12: GLOBAL WEARABLE INJECTORS MARKET SPLIT, BY APPLICATION (2016)
  • FIG 13: GLOBAL WEARABLE INJECTORS MARKET, BY END USER, $M (2012 - 2024)
  • FIG 14: GLOBAL WEARABLE INJECTORS MARKET SPLIT, BY END USER (2016)
  • FIG 15: GLOBAL WEARABLE INJECTORS MARKET, BY REGION, $M (2012 - 2024)
  • FIG 16: GLOBAL WERARABLE INJECTORS MARKET SPLIT, BY REGION (2016)
  • FIG 17: GLOBAL BODY-WORN PATCH INJECTORS MARKET, BY REGION, $M (2012 - 2024)
  • FIG 18: GLOBAL BODY-WORN PATCH INJECTORS MARKET SPLIT, BY REGION (2016)
  • FIG 19: GLOBAL OFF-BODY WORN BELT INJECTORS MARKET, BY REGION, $M (2012 - 2024)
  • FIG 20: GLOBAL OFF-BODY WORN BELT INJECTORS MARKET SPLIT, BY REGION (2016)
  • FIG 21: GLOBAL BOLUS INJECTORS MARKET, BY REGION, $M (2012 - 2024)
  • FIG 22: GLOBAL BOLUS INJECTORS MARKET SPLIT, BY REGION (2016)
  • FIG 23: GLOBAL ELECTRONINC WEARABLE INJECTORS MARKET, BY REGION, $M (2012 - 2024)
  • FIG 24: GLOBAL ELECTRONIC WEARABLE INJECTORS MARKET SPLIT, BY REGION (2016)
  • FIG 25: GLOBAL MECHANICAL WEARABLE INJECTORS MARKET, BY REGION, $M (2012 - 2024)
  • FIG 26: GLOBAL MECHANICAL WEARABLE INJECTORS MARKET SPLIT, BY REGION (2016)
  • FIG 27: GLOBAL WEARABLE INJECTORS MARKET FOR CANCER, BY REGION, $M (2012 - 2024)
  • FIG 28: GLOBAL WEARABLE INJECTORS MARKET SPLIT FOR CANCER, BY REGION (2016)
  • FIG 29: GLOBAL WEARABLE INJECTORS MARKET FOR INFECTIOUS DISEASE, BY REGION, $M (2012 - 2024)
  • FIG 30: GLOBAL WEARABLE INJECTORS MARKET SPLIT FOR INFECTIOUS DISEASE, BY REGION (2016)
  • FIG 31: GLOBAL WEARABLE INJECTORS MARKET FOR AUTOIMMUNE DISORDER, BY REGION, $M (2012 - 2024)
  • FIG 32: GLOBAL WEARABLE INJECTORS MARKET SPLIT FOR AUTOIMMUNE DISORDER, BY REGION (2016)
  • FIG 33: GLOBAL WEARABLE INJECTORS MARKET FOR CARDIOVASCULAR DISEASE, BY REGION, $M (2012 - 2024)
  • FIG 34: GLOBAL WEARABLE INJECTORS MARKET SPLIT FOR CARDIOVASCULAR DISEASE, BY REGION (2016)
  • FIG 35: GLOBAL WEARABLE INJECTORS MARKET FOR BLOOD DISORDER, BY REGION, $M (2012 - 2024)
  • FIG 36: GLOBAL WEARABLE INJECTORS MARKET SPLIT FOR BLOOD DISORDER, BY REGION (2016)
  • FIG 37: GLOBAL WEARABLE INJECTORS MARKET FOR HOMECARE, BY REGION, $M (2012 - 2024)
  • FIG 38: GLOBAL WEARABLE INJECTORS MARKET FOR HOSPITAL, BY REGION, $M (2012 - 2024)
  • FIG 39: GLOBAL WEARABLE INJECTORS MARKET SPLIT FOR HOSPITAL, BY REGION (2016)
  • FIG 40: GLOBAL WEARABLE INJECTORS MARKET FOR LAB & DIAGNOSTICS, BY REGION, $M (2012 - 2024)
  • FIG 41: GLOBAL WEARABLE INJECTORS MARKET SPLIT FOR LAB & DIAGNOSTICS, BY REGION (2016)
  • FIG 42: WORLDWIDE MAJOR MARKETS FOR WEARABLE INJECTORS (2024)
  • FIG 43: NORTH AMERICA WEARABLE INJECTORS MARKET SNAPSHOT
  • FIG 44: NORTH AMERICA WEARABLE INJECTORS MARKET, BY TYPE, $M (2012 - 2024)
  • FIG 45: NORTH AMERICA WEARABLE INJECTORS MARKET SPLIT, BY TYPE (2016)
  • FIG 46: NORTH AMERICA WEARABLE INJECTORS MARKET, BY TECHNOLOGY, $M (2012 - 2024)
  • FIG 47: NORTH AMERICA WEARABLE INJECTORS MARKET SPLIT, BY TECHNOLOGY (2016)
  • FIG 48: NORTH AMERICA WEARABLE INJECTORS MARKET, BY APPLICATION, $M (2012 - 2024)
  • FIG 49: NORTH AMERICA WEARABLE INJECTORS MARKET SPLIT, BY APPLICATION (2016)
  • FIG 50: NORTH AMERICA WEARABLE INJECTORS MARKET, BY END USER, $M (2012 - 2024)
  • FIG 51: NORTH AMERICA WEARABLE INJECTORS MARKET SPLIT, BY END USER (2016)
  • FIG 52: NORTH AMERICA WEARABLE INJECTORS MARKET, BY COUNTRY, $M (2012 - 2024)
  • FIG 53: NORTH AMERICA WEARABLE INJECTORS MARKET SPLIT, BY COUNTRY (2016)
  • FIG 54: EUROPEAN WEARABLE INJECTORS MARKET SNAPSHOT
  • FIG 55: EUROPE WEARABLE INJECTORS MARKET, BY TYPE, $M (2012 - 2024)
  • FIG 56: EUROPE WEARABLE INJECTORS MARKET SPLIT, BY TYPE (2016)
  • FIG 57: EUROPE WEARABLE INJECTORS MARKET, BY TECHNOLOGY, $M (2012 - 2024)
  • FIG 58: EUROPE WEARABLE INJECTORS MARKET SPLIT, BY TECHNOLOGY (2016)
  • FIG 59: EUROPE WEARABLE INJECTORS MARKET, BY APPLICATION, $M (2012 - 2024)
  • FIG 60: EUROPE WEARABLE INJECTORS MARKET SPLIT, BY APPLICATION (2016)
  • FIG 61: EUROPE WEARABLE INJECTORS MARKET, BY END USER, $M (2012 - 2024)
  • FIG 62: EUROPE WEARABLE INJECTORS MARKET SPLIT, BY END USER (2016)
  • FIG 63: EUROPE WEARABLE INJECTORS MARKET, BY COUNTRY, $M (2012 - 2024)
  • FIG 64: EUROPE WEARABLE INJECTORS MARKET SPLIT, BY COUNTRY (2016)
  • FIG 65: APAC WEARABLE INJECTORS MARKET SNAPSHOT
  • FIG 66: APAC WEARABLE INJECTORS MARKET, BY TYPE, $M (2012 - 2024)
  • FIG 67: APAC WEARABLE INJECTORS MARKET SPLIT, BY TYPE (2016)
  • FIG 68: APAC WEARABLE INJECTORS MARKET, BY TECHNOLOGY, $M (2012 - 2024)
  • FIG 69: APAC WEARABLE INJECTORS MARKET SPLIT, BY TECHNOLOGY (2016)
  • FIG 70: APAC WEARABLE INJECTORS MARKET, BY APPLICATION, $M (2012 - 2024)
  • FIG 71: APAC WEARABLE INJECTORS MARKET SPLIT, BY APPLICATION (2016)
  • FIG 72: APAC WEARABLE INJECTORS MARKET, BY END USER, $M (2012 - 2024)
  • FIG 73: APAC WEARABLE INJECTORS MARKET SPLIT, BY END USER (2016)
  • FIG 74: APAC WEARABLE INJECTORS MARKET, BY COUNTRY, $M (2012 - 2024)
  • FIG 75: LATIN AMERICAN WEARABLE INJECTORS MARKET SNAPSHOT
  • FIG 76: LATIN AMERICA WEARABLE INJECTORS MARKET, BY TYPE, $M (2012 - 2024)
  • FIG 77: LATIN AMERICA WEARABLE INJECTORS MARKET SPLIT, BY TYPE (2016)
  • FIG 78: LATIN AMERICA WEARABLE INJECTORS MARKET, BY TECHNOLOGY, $M (2012 - 2024)
  • FIG 79: LATIN AMERICA WEARABLE INJECTORS MARKET SPLIT, BY TECHNOLOGY (2016)
  • FIG 80: LATIN AMERICA WEARABLE INJECTORS MARKET, BY APPLICATION, $M (2012 - 2024)
  • FIG 81: LATIN AMERICA WEARABLE INJECTORS MARKET SPLIT, BY APPLICATION (2016)
  • FIG 82: LATIN AMERICA WEARABLE INJECTORS MARKET, BY END USER, $M (2012 - 2024)
  • FIG 83: LATIN AMERICA WEARABLE INJECTORS MARKET SPLIT, BY END USER (2016)
  • FIG 84: LATIN AMERICA WEARABLE INJECTORS MARKET, BY COUNTRY, $M (2012 - 2024)
  • FIG 85: LATIN AMERICA WEARABLE INJECTORS MARKET SPLIT, BY COUNTRY (2016)
  • FIG 86: MEA WEARABLE INJECTORS MARKET SNAPSHOT
  • FIG 87: MEA WEARABLE INJECTORS MARKET, BY TYPE, $M (2012 - 2024)
  • FIG 88: MEA WEARABLE INJECTORS MARKET SPLIT, BY TYPE (2016)
  • FIG 89: MEA WEARABLE INJECTORS MARKET, BY TECHNOLOGY, $M (2012 - 2024)
  • FIG 90: MEA WEARABLE INJECTORS MARKET SPLIT, BY TECHNOLOGY (2016)
  • FIG 91: MEA WEARABLE INJECTORS MARKET, BY APPLICATION, $M (2012 - 2024)
  • FIG 92: MEA WEARABLE INJECTORS MARKET SPLIT, BY APPLICATION (2016)
  • FIG 93: MEA WEARABLE INJECTORS MARKET, BY END USER, $M (2012 - 2024)
  • FIG 94: MEA WEARABLE INJECTORS MARKET SPLIT, BY END USER (2016)
  • FIG 95: PORTER'S FIVE FORCES OF COMPETITIVE POSITION ANALYSIS
  • FIG 96: COMPETITIVE POSITIONING OF THE GLOBAL WEARABLE INJECTORS MARKET, BY TYPE
  • FIG 97: COMPETITIVE BENCHMARKING OF KEY PLAYERS BASED ON TYPES OF OFFERING
  • FIG 98: GLOBAL WEARABLE INJECTORS MARKET SHARE OF KEY PLAYERS (2016)
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.